stockportfolio.pro
Phreesia, Inc. (PHR)
Healthcare · Health Information Services · NYSE
Phreesia, Inc. revenue & earnings — last 9 fiscal years
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $79.83M | $99.89M | $124.78M | $148.68M | $213.23M | $280.91M | $356.30M | $419.81M | $480.59M |
| Gross profit | — | — | — | — | — | $171.64M | $232.29M | $284.88M | $326.47M |
| Net income | $-18.19M | $-15.06M | $-20.29M | $-27.29M | $-118.16M | $-176.15M | $-136.88M | $-58.53M | $2.31M |
| Net margin | -22.8% | -15.1% | -16.3% | -18.4% | -55.4% | -62.7% | -38.4% | -13.9% | 0.5% |
Source: Phreesia, Inc. SEC filings (10-K).
What growth is priced into PHR stock?
At today's market cap of $550.13M, Phreesia, Inc. is priced for free-cash-flow growth of about -1.7% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $54.42M from the FY ending 2026-01-31). For comparison, revenue 26.4%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 9 years of Phreesia, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track PHR in your portfolio →
Phreesia, Inc. financial history by metric
About Phreesia, Inc.
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions. It also offers PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare organizations including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.
Phreesia, Inc. — frequently asked questions
What is Phreesia, Inc.'s revenue?
Phreesia, Inc. (PHR) reported revenue of $480.59M for fiscal year 2026, up 14.5% from the prior year, according to its SEC filings.
Is Phreesia, Inc. profitable?
Yes. PHR earned net income of $2.31M in fiscal 2026, a net margin of 0.5%.
What is PHR's P/E ratio?
Phreesia, Inc. trades at a price-to-earnings ratio of about 55.6 based on the latest data in our nightly-refreshed cache.
How fast is Phreesia, Inc. growing?
PHR's revenue grew at roughly 26.4% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Phreesia, Inc. have?
As of fiscal year 2026, PHR carried roughly $92.66M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Phreesia, Inc.'s gross margin?
PHR's gross margin was 67.9% in fiscal 2026 — gross profit of $326.47M on revenue of $480.59M.
What is Phreesia, Inc.'s market cap?
Phreesia, Inc. (PHR) has a market capitalization of about $550.13M, based on the latest data in our nightly-refreshed cache.
When does Phreesia, Inc.'s fiscal year end?
PHR's fiscal year ends in January. Its most recent annual filing covers the fiscal year ending 2026-01-31.
What growth is priced into PHR stock?
At today's market cap of $550.13M, Phreesia, Inc. is priced for free-cash-flow growth of about -1.7% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $54.42M from the FY ending 2026-01-31). For comparison, revenue 26.4%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from Phreesia, Inc.'s official SEC filings (10-K and 10-Q), covering 9 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.